Cavallo A - Search Results

1

Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).

Bartiromo M, Borchi B, Botta A, Bagalà A, Lugli G, Tilli M, Cavallo A, Xhaferi B, Cutruzzulà R, Vaglio A, Bresci S, Larti A, Bartoloni A, Cirami C. Bartiromo M, et al. Among authors: cavallo a. Transpl Infect Dis. 2020 Aug;22(4):e13286. doi: 10.1111/tid.13286. Epub 2020 Jul 14. Transpl Infect Dis. 2020. PMID: 32279418 Free PMC article.

2

Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020.

Lagi F, Piccica M, Graziani L, Vellere I, Botta A, Tilli M, Ottino L, Borchi B, Pozzi M, Bartalesi F, Mencarini J, Spinicci M, Zammarchi L, Pieralli F, Zagli G, Nozzoli C, Romagnoli S, Bartoloni A; COCORA working group; COCORA working group members not listed as individual author. Lagi F, et al. Euro Surveill. 2020 Apr;25(17):2000556. doi: 10.2807/1560-7917.ES.2020.25.17.2000556. Euro Surveill. 2020. PMID: 32372754 Free PMC article.

3

Ceftolozane/tazobactam for Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis adult patients: a case series.

Ottino L, Bartalesi F, Borchi B, Bresci S, Cavallo A, Baccani I, Rossolini GM, Bartoloni A. Ottino L, et al. Among authors: cavallo a. Eur J Clin Microbiol Infect Dis. 2021 Oct;40(10):2211-2215. doi: 10.1007/s10096-021-04218-1. Epub 2021 Mar 12. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33709301

4

Comparison of the efficacy, safety and durability of a switch to co-formulated RPV/TDF-TAF/FTC or DTG/ABC/3TC in virologically-suppressed HIV-1-infected patients in a single Italian centre: a cohort data analysis.

Lagi F, Botta A, Kiros ST, Meli M, Borchi B, Cavallo A, Pozzi M, Bartoloni A, Sterrantino G. Lagi F, et al. Among authors: cavallo a. Int J Antimicrob Agents. 2022 Jan;59(1):106465. doi: 10.1016/j.ijantimicag.2021.106465. Epub 2021 Oct 23. Int J Antimicrob Agents. 2022. PMID: 34699933

5

Atypical imported severe primary dengue presenting with neutrophilic leukocytosis and cardiac tamponade in a young female traveler.

Vellere I, Di Lauria N, Mantella A, Cavallo A, Bresci S, Bartoloni A, Zammarchi L. Vellere I, et al. Among authors: cavallo a. J Travel Med. 2021 Jul 7;28(5):taab074. doi: 10.1093/jtm/taab074. J Travel Med. 2021. PMID: 33987662 No abstract available.

6

Linezolid-resistant cfr-positive MRSA, Italy.

Antonelli A, D'Andrea MM, Galano A, Borchi B, Brenciani A, Vaggelli G, Cavallo A, Bartoloni A, Giovanetti E, Rossolini GM. Antonelli A, et al. Among authors: cavallo a. J Antimicrob Chemother. 2016 Aug;71(8):2349-51. doi: 10.1093/jac/dkw108. Epub 2016 Apr 12. J Antimicrob Chemother. 2016. PMID: 27073268 No abstract available.

7

Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases.

Spinicci M, Emmi G, Dies L, Barilaro A, Vitiello G, Mencarini J, Cavallo A, Bartoloni A, Bartalesi F. Spinicci M, et al. Among authors: cavallo a. Eur J Gastroenterol Hepatol. 2018 Jul;30(7):756-760. doi: 10.1097/MEG.0000000000001132. Eur J Gastroenterol Hepatol. 2018. PMID: 29649073

8

Chronic hepatitis C virus hepatitis and psoriasis: no longer a contraindication to interferon use in the era of biological agents?

Bartalesi F, Salomoni E, Cavallo A, Corti G, Pimpinelli N, Bartoloni A, Taliani G. Bartalesi F, et al. Among authors: cavallo a. Scand J Infect Dis. 2013 Apr;45(4):320-3. doi: 10.3109/00365548.2012.720026. Epub 2012 Oct 31. Scand J Infect Dis. 2013. PMID: 23113733

9

Latent tuberculosis infection in psoriasis and other dermatological immunomediated diseases: a combined approach by QuantiFERON-TB Gold and tuberculin skin tests.

Prignano F, Bartoloni A, Bartalesi F, Gori A, Ricceri F, Cavallo A, Attala L, Mantella A. Prignano F, et al. Among authors: cavallo a. Int J Dermatol. 2014 Aug;53(8):e372-4. doi: 10.1111/j.1365-4632.2012.05794.x. Epub 2014 Jun 5. Int J Dermatol. 2014. PMID: 24898978 No abstract available.

10

Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.

Mantengoli E, Luzzaro F, Pecile P, Cecconi D, Cavallo A, Attala L, Bartoloni A, Rossolini GM. Mantengoli E, et al. Among authors: cavallo a. Clin Infect Dis. 2011 Mar 1;52(5):690-1. doi: 10.1093/cid/ciq194. Epub 2011 Jan 10. Clin Infect Dis. 2011. PMID: 21220769 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

410 results

Search Page